Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer

The number of deaths from colorectal cancer in Japan continues to rise, with over 50,000 deaths recorded in 2018. In the 2024 edition, revisions to all aspects of treatment were undertaken, with corrections and additions made based on knowledge gained since the 2022 version (drug therapy) and the 2019 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer have been prepared to present standard treatment strategies, reduce disparities among institutions, avoid both unnecessary and insufficient treatment, and enhance mutual understanding between healthcare professionals and patients by making these guidelines accessible to the public. These guidelines were developed through consensus by the JSCCR Guideline Committee, following a careful review of evidence retrieved from literature searches and considering the medical insurance system and actual clinical practice in Japan. Therefore, these guidelines serve as a tool for managing colorectal cancer in real-world clinical settings. More specifically, they can be used to support obtaining informed consent from patients and selecting the most appropriate treatment method for each patient. Controversial topics were selected as clinical questions, and recommendations were provided. Each recommendation is accompanied by an evidence classification and a recommendation category, both based on consensus reached by the Guideline Committee members. This article presents the English version of the JSCCR guidelines 2024.

Authors

Institutions

Publication Details

Journal
International Journal of Clinical Oncology
Published
2025-11-04
DOI
https://doi.org/10.1007/s10147-025-02899-8
Citations
13
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
13.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer

Soichiro Ishihara, Hisato Kawakami, Hirotoshi Takiyama, Takako Eguchi Nakajima et al.
13 citations
International Journal of Clinical Oncology
Colorectal Cancer Treatments and Studies
13.59
article

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer

Soichiro Ishihara, Hisato Kawakami, Hirotoshi Takiyama, Takako Eguchi Nakajima, Yukihide Kanemitsu, Shiro Oka, Naohiko YAMAGUCHI, Yoshihiro Sakamoto, Yusuke Kinugasa, Yutaka Saito, Keiji Matsuda, Manabu Shiozawa, Hideki Ueno, Akio Shiomi, Shinichi Yamauchi, Eiji Shinozaki, Hiroya Taniguchi, Kinichi Hotta, Megumi Ishiguro, Hiroyasu Kagawa, Tamotsu Sugai, Masahiro Yoshida, Kensei Yamaguchi, Takeshi Kato, Kohei Murata, Satoshi Morita, Keisuke Uehara, Keiko Murofushi, Hirotoshi Kobayashi, Kentaro Yamazaki, Yoichi Ajioka
article en
13 citations

Abstract

The number of deaths from colorectal cancer in Japan continues to rise, with over 50,000 deaths recorded in 2018. In the 2024 edition, revisions to all aspects of treatment were undertaken, with corrections and additions made based on knowledge gained since the 2022 version (drug therapy) and the 2019 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer have been prepared to present standard treatment strategies, reduce disparities among institutions, avoid both unnecessary and insufficient treatment, and enhance mutual understanding between healthcare professionals and patients by making these guidelines accessible to the public. These guidelines were developed through consensus by the JSCCR Guideline Committee, following a careful review of evidence retrieved from literature searches and considering the medical insurance system and actual clinical practice in Japan. Therefore, these guidelines serve as a tool for managing colorectal cancer in real-world clinical settings. More specifically, they can be used to support obtaining informed consent from patients and selecting the most appropriate treatment method for each patient. Controversial topics were selected as clinical questions, and recommendations were provided. Each recommendation is accompanied by an evidence classification and a recommendation category, both based on consensus reached by the Guideline Committee members. This article presents the English version of the JSCCR guidelines 2024.

International Journal of Clinical OncologyVol. 30(12)
Hiroshima University (JP), Kyorin University (JP), Kyoto University (JP), Kanagawa Prefectural Hospital Organization (JP), Tokyo Metropolitan Komagome Hospital (JP), Shizuoka Cancer Center (JP), Osaka National Hospital (JP), Tohoku University Hospital (JP), Osaka Rosai Hospital (JP), National Institutes for Quantum Science and Technology (JP), Seirei Sakura Citizen Hospital (JP), Aichi Cancer Center (JP), National Cancer Center Hospital East (JP), The Health Care Science Institute (JP), Doai Memorial Hospital (JP), Tokyo National Hospital (JP), Southern Tohoku General Hospital (JP), Japanese Foundation For Cancer Research (JP), Kanagawa Cancer Center, National Defense Medical College (JP), Niigata University (JP), The University of Tokyo (JP), International University of Health and Welfare (JP), Nippon Medical School (JP), Teikyo University (JP)
Kindai University, Teikyo University School of Medicine, Kanazawa University
Openalex Percentile: Top 1%
Colorectal Cancer Treatments and Studies
13.59
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.